Top photo: The Kenneth Rainin Foundation complements its grants with an annual Innovations Symposium, which brings together scientific leaders to move Inflammatory Bowel Disease research forward. Photo credit: Stephanie Secrest.
Oakland, Calif. – The Kenneth Rainin Foundation has announced that it will accept applications for its Synergy Awards program from June 2 through October 2, 2017. The awards will fund teams of health investigators to pursue unconventional, collaborative research projects that will advance the study of Inflammatory Bowel Disease (IBD).
“The spirit of this award is to forge transformative collaborations,” said Laura Wilson, PhD, Director of Health Strategy and Ventures for the Rainin Foundation. “By bringing together teams of researchers to pursue groundbreaking methodologies, we hope to catalyze discoveries that will enable us to predict and prevent IBD.”
The Synergy Awards program supports teams of up to three investigators to pursue multidisciplinary, collaborative research projects for a maximum award of $100,000 per investigator, up to $300,000. The grants will fund basic, translational and clinical science projects, and encourage collaboration among scientists, clinicians and industry partners.
Applications must demonstrate that the proposed research could not be achieved without collaboration. “By encouraging synergistic projects, we will develop connections and networks that will benefit not only patients with IBD, but the scientific community as a whole,” said Wilson.
Proposals will be accepted through the Foundation’s online application system. The program is open to researchers from any nonprofit research institution worldwide. View complete program information, eligibility requirements and application guidelines.
Symposium Advances Understanding of IBD
Complementing its scientific research funding, the Foundation will host its sixth annual Innovations Symposium on July 24–25, 2017, in San Francisco. This event brings together scientific leaders, trainees, researchers and clinicians from around the world to encourage dialogue and advance the understanding of Inflammatory Bowel Disease (IBD).
This year’s Symposium will broadly focus on early onset IBD and feature international speakers and Rainin Foundation grantees who will present their work. Additionally, it will include a panel discussion to provide an opportunity for investigators to get acquainted with industry representatives who are working in translational science. For more information, visit krfoundation.org/symposium.